Special Issue: Heart Failure in the ElderlyClinical ResearchMRAs in Elderly HF Patients: Individual Patient-Data Meta-Analysis of RALES, EMPHASIS-HF, and TOPCAT
Central Illustration
Key Words
Abbreviations and Acronyms
Cited by (0)
Drs. Ferreira, Rossignol, and Zannad are supported by French National Research Agency Fighting Heart Failure grant ANR-15-RHU-0004, French PIA project Lorraine Université d’Excellence GEENAGE grant ANR-15-IDEX-04-LUE, Contrat de Plan Etat Région Lorraine, and FEDER grant IT2MP. Dr. Rossello has received support from the SEC-CNIC CARDIOJOVEN fellowship program. Dr. Rossignol has received research and travel support from Novartis; and has received personal fees from NovoNordisk, Relypsa, Vifor, Vifor Fresenius Medical Care, AstraZeneca, GrÜnenthal, Idorsia, Bayer, Servier, Corvidia, G3 pharmaceuticals, and CardioRenal (cofounder). Dr. Girerd has received honoraria from Novartis and Boehringer Ingelheim. Dr. Pitt is a consultant for Bayer, Sanofi, AstraZeneca, KBP Biosciences, and Vifor. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.